Clinical

Dataset Information

A Study of BMS-986416 With and Without Nivolumab in Select Solid Tumors


ABSTRACT: The purpose of this study is to evaluate the safety, tolerability, drug effects, drug levels and preliminary antitumor activity of BMS-986416 when administered alone and in combination with Nivolumab in participants with select advanced solid tumors.

DISEASE(S): Advanced Solid Tumors,Non-small Cell Lung Cancer (nsclc),Neoplasms

PROVIDER: 2381918 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR